Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Hackett

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Biology & Therapy|December 17, 2009
A translational end-run for a rare, genetically enigmatic tumorChristopher S Hackett, William A Weiss
Nature Reviews. Clinical Oncology|December 19, 2019
Engineering strategies to overcome the current roadblocks in CAR T cell therapySarwish Rafiq, Christopher S Hackett, Renier J Brentjens
Genome Biology|December 6, 2007
Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapyChristopher S Hackett, Aron M Geurts, Perry B Hackett
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2022
Multipurposing CARs: Same engine, different vehiclesA K M Nawshad Hossian, Christopher S Hackett, Renier J Brentjens, et al.
Cancer Research|September 7, 2007
A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant gliomaQi-Wen Fan, Christine K Cheng, Theodore P Nicolaides, et al.
Nucleic Acids Research|May 24, 2006
Structure-based prediction of insertion-site preferences of transposons into chromosomesAron M Geurts, Christopher S Hackett, Jason B Bell, et al.
Science Translational Medicine|January 6, 2012
Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastomaYvan H Chanthery, W Clay Gustafson, Melissa Itsara, et al.
Epigenetics|October 11, 2013
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancerScott J Diede, Zizhen Yao, C Chip Keyes, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Biology & Therapy|December 17, 2009
A translational end-run for a rare, genetically enigmatic tumorChristopher S Hackett, William A Weiss
Nature Reviews. Clinical Oncology|December 19, 2019
Engineering strategies to overcome the current roadblocks in CAR T cell therapySarwish Rafiq, Christopher S Hackett, Renier J Brentjens
Genome Biology|December 6, 2007
Predicting preferential DNA vector insertion sites: implications for functional genomics and gene therapyChristopher S Hackett, Aron M Geurts, Perry B Hackett
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2022
Multipurposing CARs: Same engine, different vehiclesA K M Nawshad Hossian, Christopher S Hackett, Renier J Brentjens, et al.
Cancer Research|September 7, 2007
A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant gliomaQi-Wen Fan, Christine K Cheng, Theodore P Nicolaides, et al.
Nucleic Acids Research|May 24, 2006
Structure-based prediction of insertion-site preferences of transposons into chromosomesAron M Geurts, Christopher S Hackett, Jason B Bell, et al.
Science Translational Medicine|January 6, 2012
Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastomaYvan H Chanthery, W Clay Gustafson, Melissa Itsara, et al.
Epigenetics|October 11, 2013
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancerScott J Diede, Zizhen Yao, C Chip Keyes, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Cancer Research|September 23, 2003
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumorsChristopher S Hackett, J Graeme Hodgson, Mark E Law, et al.
Pageof 3